University of Pittsburgh is Enhancing Treatment & Utilization for Depression and Emergent Suicidality
Photo by Elijah M. Henderson
University of Pittsburgh in collaboration with Kaiser Foundation Research Institute and National Institute of Mental Health (NIMH) is recruiting patients for the clinical trial of Screening Wizard- Phase 2.
Primary Care Providers (PCPs) are often uncertain about how to best refer adolescents who screen positive for depression or suicidality. Screen-positive youth who are either not in treatment, or express dissatisfaction with current treatment will be consented by an on-site research assistant (RA). Participants will answer questions via adaptive screens developed in a previous NIMH study (MH100155) for suicidal risk, anxiety, and mania. These will address perceived barriers and preferences about treatment.
Screening Wizard will be delivered by Primary Care Providers (PCPs) at well child visits, beginning with screening occurring within the waiting room which will yield decision support guidance delivered and followed by the PCP at the same visit.
The participants who are currently experiencing acute mania or psychosis, evidence of an intellectual or developmental disorder (IDD), life threatening medical condition that requires immediate treatment, or other cognitive or medical condition preventing youth from understanding study and/or participating cannot be enroled to this clinical trial.
The study will take place at the Children's Community Pediatrics (CCP- Bass Wolfson Cranberry) of Children's Hospital of Pittsburgh of UPMC, Cranberry Township, Pennsylvania; Children's Hospital of Pittsburgh Department of Neurology, Pittsburgh, Pennsylvania; Children's Primary Care Center (PCC) of Children's Hospital of Pittsburgh UPMC, Pittsburgh, Pennsylvania and UPMC Center for Adolescent and Young Adult Health, Pittsburgh, Pennsylvania, United States.
The page dedicated to this clinical trial can be found here: https://ichgcp.net/clinical-trials-registry/NCT04646369
